# The influence of human milk composition and its microbiome on the gut microecology and early growth and development of preterm infants (the YI study): protocol design and cohort profile

**Authors:** Xinyue Wang, Yan Feng, Yilan Li, Yuluyuan Tian, Simin Zhang, Jinglin Li, Jiahui Zhang, Feng Liu, Jiahe Zhou, Ting Li, Sufang Duan, Ignatius Man-Yau Szeto, Li Su, Xiaoqin Luo

PMC · DOI: 10.3389/fnut.2025.1566376 · Frontiers in Nutrition · 2025-07-30

## TL;DR

This study explores how breast milk composition and its microbiome affect the gut health and development of preterm infants in China.

## Contribution

The YI study introduces a detailed protocol for analyzing breast milk's impact on preterm infants' gut microecology and development using multi-omics techniques.

## Key findings

- The study collected biospecimens from preterm and term infants to analyze breast milk and gut microbiome interactions.
- Multi-omics techniques were applied to paired breast milk and fecal samples across six timepoints.
- The study achieved high sample collection rates and detailed data on maternal and infant health metrics.

## Abstract

Breastfeeding can reduce the risk of serious illness in preterm infants. However, the influence of human milk on the gut microecology and early development of preterm infants remains unclear.

The YI Study is a prospective cohort protocol conducted in China, designed to investigate the dynamic associations among breast milk composition, infant gut microecology, and health from a mother–breastmilk–preterm infant triad perspective. From January 2023 to May 2024, a total of 50 mother–term infant dyads and 35 mother–preterm infant dyads were enrolled and followed up at six timepoints: v1 (0–7 days), v2 (8–14 days), v3 (1 month), v4 (2 months), v5 (4 months), and v6 (6 months). Data collection included questionnaires, anthropometric measurements, and biospecimens. Questionnaires (including birth medical records, environment, feeding practices and illnesses status) and anthropometric measurements were collected at all visits. Biospecimens included paired samples of breast milk and feces were obtained at each visit, and comprehensively analyzed by multi-omics techniques. We also collected heel blood at birth to examine immune status and saliva at the v6 visit to explore the role of its constituents in dietary behaviors.

The average age of the mothers was 30.9 ± 3.5 years. The median gestational age was 36 (35, 36) weeks in the Preterm Group and 39 (38, 40) weeks in the Term group. The completion rate up to V6 was 82.9% in the Preterm Group and 94% in the Term Group. All samples were collected within the predefined visit windows, with a total of 452 breast milk, 465 infant feces, 227 maternal feces, 49 heel blood and 98 saliva.

Through ultra-early, multi-temporal, multi-sample collection, combined with multi-omics technologies, the YI study will provide an opportunity to explore the dynamic association of human milk as a complex biological system with gut microecology and health in preterm infants in depth.

## Full-text entities

- **Genes:** LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, MFGE8 (milk fat globule EGF and factor V/VIII domain containing) [NCBI Gene 4240] {aka BA46, EDIL1, HMFG, HsT19888, MFG-E8, MFGM}, NRP1 (neuropilin 1) [NCBI Gene 8829] {aka BDCA4, CD304, NP1, NRP, VEGF165R}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, KLK6 (kallikrein related peptidase 6) [NCBI Gene 5653] {aka Bssp, Klk7, PRSS18, PRSS9, SP59, hK6}
- **Diseases:** vomiting (MESH:D014839), Inflammation (MESH:D007249), gastrointestinal infections (MESH:D005767), metabolic diseases (MESH:D008659), necrotizing enterocolitis (MESH:D020345), skin rashes (MESH:D005076), pregnancy complications (MESH:D011248), daytime dysfunction (MESH:D006970), irritability (MESH:D001523), flatulence (MESH:D005414), mammary gland diseases (MESH:D010144), sepsis (MESH:D018805), overweight (MESH:D050177), preterm infants (MESH:D047928), respiratory infections (MESH:D012141), obesity (MESH:D009765), sleep disturbance (MESH:D012893)
- **Chemicals:** phospholipids (MESH:D010743), Fatty acids (MESH:D005227), glycolipids (MESH:D006017), amino acids (MESH:D000596), Lactose (MESH:D007785), essential fatty acid (MESH:D005228), lipids (MESH:D008055), silver (MESH:D012834)
- **Species:** Homo sapiens (human, species) [taxon 9606], PX clade (clade) [taxon 569578], Bifidobacterium bifidum (species) [taxon 1681], gut metagenome (species) [taxon 749906]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12343233/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12343233/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC12343233/full.md

---
Source: https://tomesphere.com/paper/PMC12343233